rs3077, HLA-DPA1

N. diseases: 16
Source: ALL
Disease Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
cervical cancer
CUI: C4048328
Disease: cervical cancer
0.010 GeneticVariation BEFREE These findings indicate that HLA-DP rs3077 and rs9277535 were candidate susceptibility markers for cervical cancer in Chinese females. 23428460 2013
Cervix carcinoma
CUI: C0302592
Disease: Cervix carcinoma
0.010 GeneticVariation BEFREE These findings indicate that HLA-DP rs3077 and rs9277535 were candidate susceptibility markers for cervical cancer in Chinese females. 23428460 2013
Cirrhosis
CUI: C1623038
Disease: Cirrhosis
0.010 GeneticVariation BEFREE However, rs3077 was not associated with the development of cirrhosis or hepatocellular carcinoma. 21402545 2011
Complete atrioventricular block
CUI: C0151517
Disease: Complete atrioventricular block
0.050 GeneticVariation BEFREE Association of CHB with SNPs rs2856718 and rs7453920 remains significant even after stratification with rs3077 and rs9277535, indicating independent effect of HLA-DQ variants on CHB susceptibility (P-value of 1.52 × 10(-21)- 2.38 × 10(-30)). 21750111 2011
Complete atrioventricular block
CUI: C0151517
Disease: Complete atrioventricular block
0.050 GeneticVariation BEFREE The genotype distribution in HBV carriers relative to those who resolved HBV showed that rs3077 and rs9277378 were significantly associated with protective effects against CHB in minor dominant model (OR = 0.45, p<0.001 and OR = 0.47, p<0.001). 24465836 2014
Complete atrioventricular block
CUI: C0151517
Disease: Complete atrioventricular block
0.050 GeneticVariation BEFREE There was no significant association between HLA-DP polymorphism (rs3077) and IFN-γ receptor-2 gene polymorphism (rs2284553) with viral activity in HBeAg-negative CHB patients. 23980639 2014
Complete atrioventricular block
CUI: C0151517
Disease: Complete atrioventricular block
0.050 GeneticVariation BEFREE However, no significant association was seen for rs3077 with progressive CHB infection versus inactive HBsAg carrier status (OR = 2.7, 95% CI: 0.6-11.1; p = 0.31). 22448225 2012
Complete atrioventricular block
CUI: C0151517
Disease: Complete atrioventricular block
0.050 GeneticVariation BEFREE We also found that the HLA-DPA1 and HLA-DPB1 genes were significantly associated with protective effects against chronic hepatitis B (CHB) in Japanese, Korean and other Asian populations, including Chinese and Thai individuals (P(meta) = 4.40×10⁻¹⁹ for rs3077 and P(meta) = 1.28×10⁻¹⁵ for rs9277542). 22737229 2012
Encephalitis, St. Louis
CUI: C0014060
Disease: Encephalitis, St. Louis
0.010 GeneticVariation BEFREE In conclusion, HLA-DP polymorphisms (rs3077 and rs9277535) were associated with SLE susceptibility and the levels of some inflammatory cytokines in SLE patients. 28094303 2017
Hepatitis B
CUI: C0019163
Disease: Hepatitis B
0.900 GeneticVariation GWASCAT A genome-wide association study of chronic hepatitis B identified novel risk locus in a Japanese population. 21750111 2011
Hepatitis B
CUI: C0019163
Disease: Hepatitis B
0.900 GeneticVariation BEFREE Recent genome-wide association studies showed that four single-nucleotide polymorphisms (SNPs) in human leukocyte antigen (HLA)-DP (rs3077 and rs9277535) and HLA-DQ (rs2856718 and rs7453920) were associated with chronic hepatitis B virus (HBV) infection in Japanese populations. 22105689 2012
Hepatitis B
CUI: C0019163
Disease: Hepatitis B
0.900 GeneticVariation BEFREE No significant correlation was shown in HLA-DP rs3077 and rs9277535 with HBV infection or liver function recovery (P < .05).Our study concluded that HLA-DP (rs3077 and rs9277535) and HLA-DQ (rs7453920) were not significantly associated with HBV recurrence or HBV susceptibility, but HLA-DQ rs7453920 was related to prognosis of liver transplant recipients. 28640108 2017
Hepatitis B
CUI: C0019163
Disease: Hepatitis B
0.900 GeneticVariation BEFREE Japanese patients (202) who were hepatitis B e antigen positive at baseline, received LAM as first-line treatment, and consented to HLA-DP genotyping (HLA-DPA1 rs3077 and HLA-DPB1 rs9277535) were categorized into two cohorts, viz., a cohort who achieved virological response without rescue therapy (cohort 1) and those who did so with rescue therapy (cohort 2). 25103089 2015
Hepatitis B
CUI: C0019163
Disease: Hepatitis B
0.900 GeneticVariation BEFREE We found that rs3077 and rs9277535 in HLA-DP significantly decreased HBV infection risks and increased HBV clearance possibility in a dose-dependent manner. 26462556 2015
Hepatitis B
CUI: C0019163
Disease: Hepatitis B
0.900 GeneticVariation BEFREE Both rs3077 and rs2284553 polymorphisms were not associated with HBV viral load in terms of allelic frequency, genotypic frequency, dominant/recessive gene action. rs9808753 (G allele) was associated with a reduced chance of "undetectable HBV DNA" for patients below the age of 50 years in allelic frequency analysis (odds ratio 0.562; 95% confidence interval, 0.326-0.967; P value = 0.037). 23980639 2014
Hepatitis B
CUI: C0019163
Disease: Hepatitis B
0.900 GeneticVariation GWASDB A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians. 19349983 2009
Hepatitis B
CUI: C0019163
Disease: Hepatitis B
0.900 GeneticVariation BEFREE A highly significant association of HLA-DPA1 rs3077 with HBV infection was observed in Caucasians. 22448225 2012
Hepatitis B
CUI: C0019163
Disease: Hepatitis B
0.900 GeneticVariation BEFREE HLA-DP SNPs rs3077, rs9277378 and rs3128917 were associated with chronicity of HBV disease in the Chinese. 23825586 2013
Hepatitis B
CUI: C0019163
Disease: Hepatitis B
0.900 GeneticVariation GWASDB Genome-wide association study confirming association of HLA-DP with protection against chronic hepatitis B and viral clearance in Japanese and Korean. 22737229 2012
Hepatitis B
CUI: C0019163
Disease: Hepatitis B
0.900 GeneticVariation BEFREE The results showed that rs2856718, rs3077, rs9277535 and rs9275572 were associated with HBV infection (p = 0.0003, OR = 1.351, CI = 1.147-1.591; p = 0.041, OR = 1.20, CI = 1.007-1.43; p = 0.045, OR = 1.198, CI = 1.004-1.43 and p = 0.0018, OR = 0.776, CI = 0.662-0.910, respectively). 24465366 2014
Hepatitis B
CUI: C0019163
Disease: Hepatitis B
0.900 GeneticVariation BEFREE Viral and host predictors of relapse were evaluated, including hepatitis B virus (HBV) surface antigen (HBsAg) level, anti-HBV core antibody level, and presence of single-nucleotide polymorphisms in the genes encoding the receptors NTCP (rs2296651) and CTLA4 (rs231775) and in the 3' untranslated regions of the genes encoding HLA-DPA1 (rs3077) and HLA-DPB1 (rs9277535); posttherapy predictors of relapse were also investigated. 29300980 2018
Hepatitis B
CUI: C0019163
Disease: Hepatitis B
0.900 GeneticVariation GWASDB A genome-wide association study identified new variants associated with the risk of chronic hepatitis B. 23760081 2013
Hepatitis B
CUI: C0019163
Disease: Hepatitis B
0.900 GeneticVariation GWASDB A genome-wide association study of chronic hepatitis B identified novel risk locus in a Japanese population. 21750111 2011
Hepatitis B
CUI: C0019163
Disease: Hepatitis B
0.900 GeneticVariation BEFREE Our results demonstrated, for the first time, that expression of HLA-DPA1 alleles and rs3077 affected the risk of HBV infection. 30267609 2019
Hepatitis B
CUI: C0019163
Disease: Hepatitis B
0.900 GeneticVariation BEFREE Two single nucleotide polymorphisms (SNP), rs3077 near HLA-DPA1 region and rs9277535 near HLA-DPB1 region, have been shown to be associated with HBV persistence after acute HBV infection. 23326374 2013